The University of Melbourne

Participating Unit: 
Faculty of Medicine, Dentistry and Health Science, Department of Otolaryngology
HEARing CRC Member type: 
Core
Organisation type: 
Academic and Medical Research

About this Organisation

Research
The Department has developed to be a leading international player in hearing research, largely due to its role in the development and improvement of cochlear implants and their application. The cochlear implant now provides hearing to over 100,000 completely or profoundly deaf people in over 60 countries around the world. There is also an increasing role in clinical audiology research in other fields such as vestibular pathologies and paediatric management.

Teaching
The Department runs the only training course for the audiology profession in Victoria. The Masters of Clinical Audiology has grown by a factor of three over the last 12 years in terms of students and staff, largely due to the growth and increasing demand for audiological services in the community. This demand is likely to increase in the medium term and the need to accommodate additional audiology students in years to come has led to the relocation of the teaching component of the department to new facilities in Swanston St

Clinical
The Department manages all audiology services within the hospital and the precinct (approximately 20,000 patient services per annum). The key personnel coordinating the major clinical areas are either University staff members (Richard Dowell, Gary Rance, Angela Marshall) or closely linked with the University teaching and research (Rod Hollow, Dominic Power, Jaime Leigh, Alison Hennessy). This involvement with the clinical services is vital for both the clinical teaching in audiology and the researchKey

Relationships
All of the functions mentioned above that give the University Department its strong national and international reputation are dependent on the activities and support of the Royal Victorian Eye and Ear Hospital. This is not only through direct funding of research staff, but also through the provision of infrastructure and the access to clinical services and patients which is vital to the teaching and research.

Project involvement

Program Project-ID Title Project Leader
C1 C1.1.1 Clinical Trials and Product Validation Kerrie Plant
R1 R1.1.1a Central Auditory Processing Abnormalities in Adults Gary Rance
R1 R1.2.1a Genetic screening and resistance - human genome collaborative study (COMPLETE) Henrik Dahl
R1 R1.2.1b Use of pharmaceuticals in hearing loss prevention (COMPLETE) Shehnaaz Manji
R1 R1.2.2 Genomic & molecular therapeutic approaches to environmental and age-related hearing loss Doug Hilton
R2 R2.0.1 Reproducing the Pure Tone: CURRENTLY SUSPENDED
R2 R2.2.1 Bilateral signal processing for use in hearing aids and/or cochlear implants Jorge Mejia
R2 R2.2.2 Bilateral stimulus optimisation for cochlear implants Richard vanHoesel
R2 R2.3.1 Improved coding and transduction of pitch, fine spatio-temporal structure and speech in noise for cochlear implant users Andrew Vandali
R2 R2.4.1 Unilateral Front-end Processing John Heasman
R2 R2.5.1 Improving cochlear implant performance through use of neural models (COMPLETED) Stephen OLeary
R3 R3.1.1 Biosafety studies for electrical parameters, materials and designs Carrie Newbold
R3 R3.2.1 Optimisation of electro-neural interface Carrie Newbold
R3 R3.2.2 Enhanced electrode design Rob Briggs
R3 R3.3.1a Development of improved totally implantable TIKI microphone system (COMPLETED) Eric Burwood
R3 R3.3.1b Sealable microphone for cochlear implant system John Heasman
R3 R3.3.2 Implantable Sensor Design
R3 R3.4.1 Electro-acoustic implant design: CURRENTLY SUSPENDED
R3 R3.5.1 BAHA & ME implant enhancement & optimisation: CURRENTLY SUSPENDED
R3 R3.6.1 Noise reduction in listening devices - speech referenced limiting in telecommunications and computing: See Commercialisation project C1.4.3 Michael Fisher
R3 R3.6.2 Active noise control core technology ~ literature review (COMPLETED) Michael Fisher
R3 R3.6.3 Active noise control hearing protection: See Commercialisation project C1.4.1 Mark Harrison
R4 R4.1.2 Overcoming barriers to referral for hearing aids and/or cochlear implants Robert Cowan
R4 R4.2.2 Approaches to enhancing habilitation in children Dimity Dornan
R4 R4.2.3 Approaches to improving literacy in children using hearing aids and cochlear implants
R4 R4.4.2 Improved imaging of cochlear implant electrodes (COMPLETED) Stephen OLeary
R4 R4.6.1 Evidence-based understanding of device selection and management decisions Richard Dowell
R4 R4.6.3 Derivation and production of the NAL-NL2 prescription procedure: see Commercialisation project C1.4.2. Harvey Dillon
R4 R4.6.4 Management of children with auditory neuropathy ~ merged with project R4.6.2 Catherine McMahon
R4 R4.6.6 Prescription procedure for hybrid devices Paola Incerti
R4 R4.6.7 Device evaluation, verification fine-tuning methods (COMPLETED) Gitte Keidser